At-home gut microbiome tests are trending, selling insights to the curious, empowerment to the chronically ill and a claimed ...

Key Takeaways Dr. George Tidmarsh resigned Sunday while under investigationTidmarsh says he was targeted after questioning a ...

Sarepta Therapeutics' shares plunged nearly 40% in premarket trading on Tuesday as failure of two of its approved drugs for a ...

Two more people have died and several others have been hospitalized in connection with a listeria outbreak linked to recalled ...

Recursion's approach is intriguing, as evidenced by the fact that several of the world's largest pharmaceutical companies ...

The Food and Drug Administration has initiated a Class II recall of 141,984 bottles of atorvastatin calcium after tests ...

Teva Pharmaceuticals USA, based in Parsippany, New Jersey, issued a voluntary recall on Oct. 7 for some of the prazosin ...

The FDA and CDC are investigating a Salmonella outbreak tied to moringa leaf powder from India. Member’s Mark Super Greens ...

FDA announces major reforms to streamline biosimilar approvals, potentially saving Americans billions on prescription drug ...

Compass Pathways, which is developing a psilocybin treatment for severe depression, said it now expects an earlier decision ...

Telehealth company Hims & Hers Health Inc. said late Monday it is in “active discussions” with Denmark’s Novo Nordisk A/S to ...

2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: Regulus Therapeutics went up 120%; 89bio went up 85%; Chimerix gained 69% and ...